Concord Wealth Partners’s Bio-Techne TECH Stock Holding History

Concord Wealth Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.11K	Buy	+44	New	+$2.38K	﹤0.01%	715
2026 Q1	–	Sell	-44	Closed	-$2.59K	–	720
2025 Q4	$2.59K	Hold	44	–	–	﹤0.01%	690
2025 Q3	$2.45K	Hold	44	–	–	﹤0.01%	701
2025 Q2	$2.26K	Buy	44 +10	+29%	+$502	﹤0.01%	711
2025 Q1	$1.99K	Hold	34	–	–	﹤0.01%	674
2024 Q4	$2.45K	Hold	34	–	–	﹤0.01%	692
2024 Q3	$2.72K	Hold	34	–	–	﹤0.01%	713
2024 Q2	$2.44K	Hold	34	–	–	﹤0.01%	652
2024 Q1	$2.39K	Buy	+34	New	+$2.43K	﹤0.01%	735
2023 Q4	–	Sell	-84	Closed	-$5.72K	–	1009
2023 Q3	$5.72K	Hold	84	–	–	﹤0.01%	697
2023 Q2	$6.86K	Buy	84 +56	+200%	+$4.5K	﹤0.01%	657
2023 Q1	$2.08K	Sell	28 -56	-67%	-$4.32K	﹤0.01%	803
2022 Q4	$6.96K	Buy	+84	New	+$6.67K	﹤0.01%	694
2022 Q3	–	Sell	-64	Closed	-$6K	–	1037
2022 Q2	$6K	Sell	64 -488	-88%	-$45.7K	﹤0.01%	796
2022 Q1	$60K	Sell	552 -12	-2%	-$1.24K	0.02%	396
2021 Q4	$73K	Buy	564 +484	+605%	+$59.3K	0.02%	368
2021 Q3	$10K	Sell	80 -324	-80%	-$39.4K	﹤0.01%	471
2021 Q2	$45K	Buy	404 +72	+22%	+$7.58K	0.01%	374
2021 Q1	$32K	Buy	+332	New	+$30.3K	0.01%	408

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Concord Wealth Partners's TECH Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Bio-Techne (TECH) in Q2 2026: 44 shares worth $3.11K. The stake represents ﹤0.01% of the portfolio and ranks #715 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in TECH as recently as Q4 2025.

Concord Wealth Partners first reported a position in TECH in Q1 2021 and has held it in 19 quarters since. The position peaked at $73K in Q4 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Concord Wealth Partners held 44 shares of Bio-Techne worth $3.11K as of Q2 2026.
Bio-Techne was a new Concord Wealth Partners position in Q2 2026.
Bio-Techne made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #715 holding.
Concord Wealth Partners first reported a position in Bio-Techne in Q1 2021 and has held it in 19 quarters since.
Concord Wealth Partners's Bio-Techne position peaked at $73K in Q4 2021.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.